Literature DB >> 12235283

Get a ligand, get a life: integrins, signaling and cell survival.

Dwayne G Stupack1, David A Cheresh.   

Abstract

Programmed cell death is crucial for the development and maintenance of multicellular organisms. The decision to live, or to die, depends, at the cellular level, upon the cell's interaction with extracellular cues that trigger cell signaling pathways promoting survival or death. The extracellular matrix (ECM) influences the execution of the apoptotic program through the actions of adhesion receptors. Among these, integrins initiate a variety of downstream signaling events in response to ECM ligation. Integrins directly activate survival pathways via the PI 3-kinase and MAPK pathways and act as essential cofactors for their stimulation by growth factors. Conversely, elevated integrin expression in the absence of appropriate ligands, or in the presence of natural or synthetic antagonists, can promote apoptosis under otherwise permissive growth conditions. Integrins thus act in a crucial biosensory role, coordinating survival or death responses as a function of ECM composition. This dual function provides an elegant mechanism through which tissue-remodeling events may regulate cell death or survival in a temporal, ECM-governed manner.

Mesh:

Substances:

Year:  2002        PMID: 12235283     DOI: 10.1242/jcs.00071

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  180 in total

1.  Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst.

Authors:  Christoph Rader; Subhash C Sinha; Mikhail Popkov; Richard A Lerner; Carlos F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

2.  The miR-183/ItgA3 axis is a key regulator of prosensory area during early inner ear development.

Authors:  Priscilla Van den Ackerveken; Anaïs Mounier; Aurelia Huyghe; Rosalie Sacheli; Pierre-Bernard Vanlerberghe; Marie-Laure Volvert; Laurence Delacroix; Laurent Nguyen; Brigitte Malgrange
Journal:  Cell Death Differ       Date:  2017-08-04       Impact factor: 15.828

Review 3.  Dependence receptors: between life and death.

Authors:  P Mehlen; C Thibert
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

Review 4.  To move or not to move? Semaphorin signalling in cell migration.

Authors:  Luca Tamagnone; Paolo M Comoglio
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

5.  Modeling the effect of deregulated proliferation and apoptosis on the growth dynamics of epithelial cell populations in vitro.

Authors:  Jörg Galle; Markus Loeffler; Dirk Drasdo
Journal:  Biophys J       Date:  2004-10-08       Impact factor: 4.033

6.  Functional interaction of CD154 protein with α5β1 integrin is totally independent from its binding to αIIbβ3 integrin and CD40 molecules.

Authors:  Youssef El Fakhry; Haydar Alturaihi; Daniel Yacoub; Lihui Liu; Wenyan Guo; Claire Leveillé; Daniel Jung; Lara Bou Khzam; Yahye Merhi; John A Wilkins; Hongmin Li; Walid Mourad
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

Review 7.  Brain endothelial cell death: modes, signaling pathways, and relevance to neural development, homeostasis, and disease.

Authors:  Maria Teresa Rizzo; H Anne Leaver
Journal:  Mol Neurobiol       Date:  2010-04-21       Impact factor: 5.590

8.  Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma.

Authors:  Meghan C Brown; Izabela Staniszewska; Philip Lazarovici; George P Tuszynski; Luis Del Valle; Cezary Marcinkiewicz
Journal:  Neuro Oncol       Date:  2008-12       Impact factor: 12.300

9.  Expression of periostin and its clinicopathological relevance in gastric cancer.

Authors:  Jun-Sheng Li; Guang-Wen Sun; Xiao-Ying Wei; Wen-Hao Tang
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

10.  Integrins protect cardiomyocytes from ischemia/reperfusion injury.

Authors:  Hideshi Okada; N Chin Lai; Yoshitaka Kawaraguchi; Peter Liao; Jeffrey Copps; Yasuo Sugano; Sunaho Okada-Maeda; Indroneal Banerjee; Jan M Schilling; Alexandre R Gingras; Elizabeth K Asfaw; Jorge Suarez; Seok-Min Kang; Guy A Perkins; Carol G Au; Sharon Israeli-Rosenberg; Ana Maria Manso; Zheng Liu; Derek J Milner; Stephen J Kaufman; Hemal H Patel; David M Roth; H Kirk Hammond; Susan S Taylor; Wolfgang H Dillmann; Joshua I Goldhaber; Robert S Ross
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.